Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis

AIMS: Sodium‐glucose cotransporter 2 (SGLT2) inhibitors have been shown to be an effective therapy in improving heart failure outcomes. We conducted a meta‐analysis of randomized controlled trials to evaluate the efficacy of SGLT2 inhibitors in heart failure patients with either a reduced or preserv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Arjun K., Dhingra, Nitish K., Hibino, Makoto, Gupta, Vijay, Verma, Subodh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934917/
https://www.ncbi.nlm.nih.gov/pubmed/35112512
http://dx.doi.org/10.1002/ehf2.13805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934917/
https://www.ncbi.nlm.nih.gov/pubmed/35112512
http://dx.doi.org/10.1002/ehf2.13805

Ejemplares similares